InflammaSense

InflammaSense is a small company based in the United States, specializing in the development of medical devices. With a team of three employees, InflammaSense focuses on creating innovative solutions to address critical healthcare challenges. InflammaSense offers a cutting-edge device, designed to detect the early signs of sepsis. This compact device continuously monitors conventional biological signals like ECG, respiratory rate, and oxygen saturation, along with a novel neural signal, utilizing patented technology. The system seamlessly integrates with existing vital sign monitoring systems, ensuring minimal disruption to clinical workflows. The company's device is powered by advanced machine-learning algorithms, providing clinicians with precise risk scores and timely sepsis alarms. InflammaSense emphasizes patient comfort and offers 24/7 continuous monitoring and support for healthcare teams. Backed by rigorous clinical trials and peer-reviewed research, InflammaSense presents a reliable clinical decision support tool for sepsis management. For more information or to explore integration options with existing healthcare systems, visit inflammasense.com. InflammaSense is compatible with EHR platforms such as Epic App Orchard and Cerner App.